NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $339,000 | -65.2% | 1,529 | -79.2% | 0.00% | -75.0% |
| Q1 2021 | $973,000 | -79.5% | 7,358 | -73.2% | 0.00% | -80.0% |
| Q4 2020 | $4,750,000 | -12.9% | 27,453 | -43.9% | 0.02% | -20.0% |
| Q3 2020 | $5,451,000 | -52.8% | 48,968 | -74.9% | 0.02% | -55.4% |
| Q2 2020 | $11,559,000 | +204.7% | 194,923 | +246.0% | 0.06% | +133.3% |
| Q1 2020 | $3,793,000 | +116.6% | 56,328 | +171.0% | 0.02% | +166.7% |
| Q4 2019 | $1,751,000 | +152.7% | 20,783 | +124.3% | 0.01% | +125.0% |
| Q3 2019 | $693,000 | -49.7% | 9,265 | -57.5% | 0.00% | -42.9% |
| Q2 2019 | $1,378,000 | +34.3% | 21,799 | +2.3% | 0.01% | +16.7% |
| Q1 2019 | $1,026,000 | -46.0% | 21,299 | -41.2% | 0.01% | -40.0% |
| Q3 2018 | $1,899,000 | +67.5% | 36,244 | 0.0% | 0.01% | +66.7% |
| Q2 2018 | $1,134,000 | – | 36,244 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |